Bioscience Chapter Database :: 3543 Chapters Now Online

Chapter category:

Clinical Assessment in the Spondyloarthropathies

This chapter appears in the following book:

Molecular Mechanisms
of Spondylorthropathies

Edited by: Carlos López-Larrea
ISBN: TBA
» Get more information about this book at landesbioscience.com «

Chapter authors:
Ruth Wittoek and Herman Mielants


[+] view image
In order to measure disease activity, progression and response to therapy, it is important to use accurate, reliable and feasible outcome measures that can ideally be used in longitudinal cohorts, clinical trials and clinical practice.rnWith emerging therapies, the focus on the methodology of outcome assessment has increased to ensure that discriminant and responsive instruments are used.rnThis chapter reviews available measures of three major areas of disease impact in the spondyloarthropathies (disease activity, structural damage and functioning) and discusses the relevance for use in clinical practice. First, the outcome measures available for the assessment of different domains in ankylosing spondylitis, composite‑indices and response criteria for use in clinical trials and clinical practice in ankylosing spondylitis are discussed. Secondly, the performance of these in psoriatic arthritis and more disease‑specific instruments in psoriatic arthritis are discussed.

Ruth Wittoek

Herman Mielants
Department of Rheumatology, University Hospital Ghent, De Pintelaan, Gent, België

» Access chapter for $19



Additional chapters from this book:

Biochemical Features of Hla‑B27 and Antigen Processing

Simon J. Powis, Susana G. Santos and Antony N. Antoniou

The strong association of the human MHC class I allele HLA‑B27 with the development of the chronic inflammatory disease ankylosing spondylitis (AS) is clear and has been known for over three dec...

Synovial and Mucosal Immunopathology in Spondyloarthritis

Bernard Vandooren, Paul P. Tak and Dominique Baeten

Chronic inflammation of musculoskeletal structures is the most prominent disease manifestation of SpA. More specifically, the axial disease affects the spine, the sacroiliac joints and the hips. Perip...

Dendritic Cell: T-Cell Interactions in Spondyloarthritis

J.S. Hill Gaston, Lorna B. Jarvis, Libin Zhang and Jane C. Goodall

The discovery of the association between spondyloarthritis (SpA) and HLA‑B27 inevitably turned the spotlight on T‑lymphocytes as the cells which recognize peptide antigens within the bindi...

Animal Models of Spondyloarthritis

Joel D. Taurog

Animal models are available for the study of several different aspects of spondyloarthritis. The models include naturally occurring spontaneous disorders in primates and rodents, spontaneous disorders...

Spondyloarthritis, Diffuse Idiopathic Skeletal Hyperostosis and Chondrocalcinosis (DISH)

Jácome Bruges Armas, Ana Rita Couto and Bruno Filipe Bettencourt

The authors describe the main clinical and radiological findings of common enthesopathic disorders—Spondylarthritis (SpA), Chondrocalcinosis/calcium pyrophosphate dehydrate crystal deposition disease ...

HLA‑B27‑Bound Peptide Repertoires: Their Nature, Origin and Pathogenetic Relevance

Jose A. López de Castro

Peptide binding is a central biological property of HLA‑B27. The availability of HLA‑B27 subtypes differentially associated to ankylosing spondylitis provides a unique tool to explore the ...

Genomewide Screens in Ankylosing Spondylitis

Matthew A. Brown

Efforts to identify genes other than HLA‑B27 in AS have been driven by the strength of the evidence from genetic epidemiology studies indicating that HLA‑B27, although a major gene in AS, ...

Bone Formation Versus Bone Resorption in Ankylosing Spondylitis

Georg Schett

Ankylosing spondylitis (AS) and other forms of seronegative spondylarthritis (SpA) are characterized by two major processes in joints‑ the first is chronic inflammation and the second is progres...

HLA‑B27 and Host‑Pathogen Interaction

Anna S. Sahlberg, Kaisa Granfors and Markus A. Penttinen

HLA‑B27 is a risk factor closely associated to spondyloarthropathies (SpA). One form of SpA is reactive arthritis (ReA), which develops as a complication after certain bacterial infections (e.g....

Innate Immunity of Spondyloarthritis: The Role of Toll‑Like Receptors

Robert D. Inman

Amongst the spondyloarthropathies (SpA), the relationship of host susceptibility and environmental triggers is best seen in reactive arthritis (ReA). There are several points from the clinical studies...

The Enthesis Organ Concept and its Relevance to the Spondyloarthropathies

Michael Benjamin and Dennis McGonagle

A characteristic feature of the spondyloarthropathies is inflammation at tendon or ligament attachment sites. This has traditionally been viewed as a focal abnormality, even though the inflammatory re...

RankL/Rank as Key Factors for Osteoclast Development and Bone Loss in Arthropathies

Andreas Leibbrandt and Josef M. Penninger

Osteoporosis or rheumatoid arthritis are bone diseases affecting hundreds of millions of people worldwide and thus pose a tremendous burden to health care. Ground‑breaking discoveries made in ba...

Biomarkers in Spondyloarthropathies

Chun-Hsiung Chen, David Tak Yan Yu and Chung-Tei Chou

The study of biomarkers in spondyloarthropathy (SpA) has emerged to be a very important field of research. This is particularly because the two commonly used biomarkers, erythrocyte sedimentation rate...

HLA‑B27 Misfolding and Spondyloarthropathies

Robert A. Colbert, Monica L. DeLay, Gerlinde Layh-Schmitt and Dawn P. Sowders

HLA‑B27 plays a central role in the pathogenesis of many spondyloarthropathies and in particular ankylosing spondylitis. The observation that the HLA‑B27 heavy chain has a tendency to misf...

The Role of B27 Heavy Chain Dimer Immune Receptor Interactions in Spondyloarthritis

Simon Kollnberger and Paul Bowness

HLA‑B27 (B27) is strongly associated with spondyloarthopathy. The classical role of B27 is to present peptides from intracellular pathogens as a heterotrimeric complex with β2 microglobulin...

Clinical Assessment in the Spondyloarthropathies

Ruth Wittoek and Herman Mielants

In order to measure disease activity, progression and response to therapy, it is important to use accurate, reliable and feasible outcome measures that can ideally be used in longitudinal cohorts, cli...


SIGN IN

Email:


Password:


lost password?




[ Home | Authors | Editors | Custom Books | Chapter Reprints | Subscribe | Contact | Biotoons ]